AHA Coding Clinic® for HCPCS - 2010 Quarter 3; FOR your INFORMATION
New HCPCS C Codes for Several Drugs and Biologicals
Several HCPCS C-codes listed below (ie., C9262 , C9264 , C9265 , C9266 , C9267 , C9268 , C9367 ), for drugs and biologicals were granted pass-through status as of July 1, 2010. Additionally, there is a new HCPCS C-code, C9800 for the reporting of dermal injection procedure(s). This new HCPCS code C9800 includes both the products and the procedure, which is assigned to a separately payable APC. Note that C9800 is not a pass-through C-code. These new HCPCS C-codes became effective as of July 1, 2010. HCPCS Code Long Descriptor Comments C9262 Fludarabine phosphate, oral, 1 mg HCPCS C-code C9262 was deleted 06/30/2010 and...
Subscribe or sign in to view the full article.
Article Overview
This article reviews a July 1, 2010 update to HCPCS C-codes affecting certain drugs, biologicals, and a dermal injection procedure reporting category. It is relevant to outpatient hospital coders, billing staff, and revenue cycle professionals who track temporary and pass-through code updates. The article also notes a deleted/replaced code and identifies the general payment status context for the new codes.
Why This Topic Matters
Code updates like these affect charge capture, claim reporting, and payment categorization in outpatient settings. Keeping current with effective-date changes and code replacements helps reduce reporting errors and supports accurate billing workflows.
What You Will Learn
- Which HCPCS C-codes were newly highlighted in the update
- How the article frames the effective date for the changes
- How the article distinguishes drug/biological reporting from a procedure-related code update
- That one code was deleted and replaced effective July 1, 2010
Who Should Read This
- Hospital outpatient coders
- Billing and reimbursement staff
- Revenue cycle teams
- Coding educators and auditors
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com